| Gut microbiome pattern reflects healthy ageing and predicts survival in humans T Wilmanski, C Diener, N Rappaport, S Patwardhan, J Wiedrick, ... Nature metabolism 3 (2), 274-286, 2021 | 239 | 2021 |
| Blood metabolome predicts gut microbiome α-diversity in humans T Wilmanski, N Rappaport, JC Earls, AT Magis, O Manor, J Lovejoy, ... Nature biotechnology 37 (10), 1217-1228, 2019 | 184 | 2019 |
| Pyruvate carboxylase supports the pulmonary tropism of metastatic breast cancer A Shinde, T Wilmanski, H Chen, D Teegarden, MK Wendt Breast Cancer Research 20, 1-12, 2018 | 72 | 2018 |
| Inhibition of pyruvate carboxylase by 1α, 25-dihydroxyvitamin D promotes oxidative stress in early breast cancer progression T Wilmanski, X Zhou, W Zheng, A Shinde, SS Donkin, M Wendt, ... Cancer letters 411, 171-181, 2017 | 68 | 2017 |
| Multi-omic biological age estimation and its correlation with wellness and disease phenotypes: a longitudinal study of 3,558 individuals JC Earls, N Rappaport, L Heath, T Wilmanski, AT Magis, NJ Schork, ... The Journals of Gerontology: Series A 74 (Supplement_1), S52-S60, 2019 | 38 | 2019 |
| 1α, 25-dihydroxyvitamin D inhibits de novo fatty acid synthesis and lipid accumulation in metastatic breast cancer cells through down-regulation of pyruvate carboxylase T Wilmanski, K Buhman, SS Donkin, JR Burgess, D Teegarden The Journal of nutritional biochemistry 40, 194-200, 2017 | 34 | 2017 |
| Longitudinal analysis reveals transition barriers between dominant ecological states in the gut microbiome R Levy, AT Magis, JC Earls, O Manor, T Wilmanski, J Lovejoy, ... Proceedings of the National Academy of Sciences 117 (24), 13839-13845, 2020 | 32 | 2020 |
| 1α, 25-dihydroxyvitamin D inhibits the metastatic capability of MCF10CA1a and MDA-MB-231 cells in an in vitro model of breast to bone metastasis T Wilmanski, A Barnard, MR Parikh, J Kirshner, K Buhman, J Burgess, ... Nutrition and cancer 68 (7), 1202-1209, 2016 | 22 | 2016 |
| Gut microbiome pattern reflects healthy ageing and predicts survival in humans. Nat Metab 3: 274–286 T Wilmanski, C Diener, N Rappaport, S Patwardhan, J Wiedrick, ... | 16 | 2021 |
| From taxonomy to metabolic output: what factors define gut microbiome health? T Wilmanski, N Rappaport, C Diener, SM Gibbons, ND Price Gut microbes 13 (1), 1907270, 2021 | 15 | 2021 |
| Heterogeneity in statin responses explained by variation in the human gut microbiome T Wilmanski, SA Kornilov, C Diener, MP Conomos, JC Lovejoy, ... Med 3 (6), 388-405. e6, 2022 | 12 | 2022 |
| Genome–microbiome interplay provides insight into the determinants of the human blood metabolome C Diener, CL Dai, T Wilmanski, P Baloni, B Smith, N Rappaport, L Hood, ... Nature Metabolism, 1-13, 2022 | 9 | 2022 |
| The geometry of clinical labs and wellness states from deeply phenotyped humans A Zimmer, Y Korem, N Rappaport, T Wilmanski, P Baloni, K Jade, ... Nature communications 12 (1), 3578, 2021 | 8 | 2021 |
| Towards early risk biomarkers: serum metabolic signature in childhood predicts cardio-metabolic risk in adulthood X Ojanen, R Cheng, T Törmäkangas, N Rappaport, T Wilmanski, N Wu, ... EBioMedicine 72, 103611, 2021 | 7 | 2021 |
| D3T acts as a pro-oxidant in a cell culture model of diabetes-induced peripheral neuropathy MA Stochelski, T Wilmanski, M Walters, JR Burgess Redox Biology 21, 101078, 2019 | 5 | 2019 |
| Healthy aging and the human gut microbiome: why we cannot just turn back the clock T Wilmanski, SM Gibbons, ND Price Nature Aging 2 (10), 869-871, 2022 | 2 | 2022 |
| Multiomic signatures of body mass index identify heterogeneous health phenotypes and responses to a lifestyle intervention K Watanabe, T Wilmanski, C Diener, JC Earls, A Zimmer, B Lincoln, ... Nature medicine, 1-13, 2023 | 1 | 2023 |
| Generally-healthy individuals with aberrant bowel movement frequencies show enrichment for microbially-derived blood metabolites associated with impaired kidney function. JP Johnson, C Diener, AE Levine, T Wilmanski, DL Suskind, A Ralevski, ... bioRxiv, 2023.03. 04.531100, 2023 | 1 | 2023 |
| Microbial community-scale metabolic modeling predicts personalized short-chain-fatty-acid production profiles in the human gut. N Bohmann, T Wilmanski, L Levy, J Lampe, T Gurry, N Rappaport, ... bioRxiv, 2023.02. 28.530516, 2023 | 1 | 2023 |
| 1α,25‐Dihydroxyvitamin D3 Inhibits De Novo Fatty Acid Synthesis and Neutral Lipid Accumulation in Metastatic Breast Cancer Cells Through Downregulation of … TM Wilmanski, K Buhman, SS Donkin, J Burgess, D Teegarden The FASEB Journal 31, 790.14-790.14, 2017 | 1 | 2017 |
Noa RappaportSenior Research scientist, Institute for Systems BiologyVerified email at systemsbiology.org
